Company: RGNX
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0000950170-25-038770
Chunk: 292

Company: REGENXBIO Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 1B
Chunk 292
---
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

    Signature 
     
    Title 
     
    Date 

    /s/ Curran Simpson
     
    President, Chief Executive Officer and 
     
    March 13, 2025

    Curran Simpson
     
    Director (Principal Executive Officer)

    /s/ Mitchell Chan
     
    Chief Financial Officer
     
    March 13, 2025

    Mitchell Chan
     
    (Principal Financial and Accounting Officer)

    /s/ Kenneth T. Mills
     
    Chairman of the Board of Directors
     
    March 13, 2025

    Kenneth T. Mills

    /s/ Jean Bennett
     
    Director
     
    March 13, 2025

    Jean Bennett

    /s/ Allan M. Fox
     
    Director
     
    March 13, 2025

    Allan M. Fox

    /s/ Alexandra Glucksmann
     
    Director
     
    March 13, 2025

    Alexandra Glucksmann

    /s/ A.N. “Jerry” Karabelas
     
    Director
     
    March 13, 2025

    A.N. “Jerry” Karabelas

    /s/ George Migausky
     
    Director
     
    March 13, 2025

    George Migausky

    /s/ David C. Stump
     
    Director
     
    March 13, 2025

    David C. Stump

    /s/ Daniel Tassé
     
    Director
     
    March 13, 2025

    Daniel Tassé

    /s/ Jennifer Zachary
     
    Director
     
    March 13, 2025

    Jennifer Zachary

131